Skip to content

RDMed

Active
Private limited companyfounded 2022active for 4 yearsGrand'Route(Flh) 506, 4400 Flémalle, BelgiumKBO/BCE: BE 0791.532.866
Summary

RDMed has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,225 and a net result of €64,527. Equity has been growing by about 23% per year since 2023. Its solvency ranks better than 26% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-09-2022 Normal situation
Activity
General medical practice NACE 86210and 2 others
Establishment unit
2.336.337.050 4400 Flémalle, since 28-09-2022
Financial year end
31 December
Peppol
Reachable since 12-01-2026

Board and ownership

Board

Financial position

55 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€93,066
▼ 5.2%
Turnover
≈ €210,000
estimated
Profit
€64,527
▼ 5.8%
Equity
€57,225
▼ 40.7%
Total assets
€185,830
▲ 21.4%
  • 2025 accounts filed 91 days after the deadline
Score breakdownraises riskCapped at 59: a confirmed filing findingLast filed accounts filed 91 days late; 2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.40, cash €110,371Figures for financial year 2025 (filed on 30-10-2026)Show the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 42% of micro companies in human health (NACE 86)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 56-32
equity 30.8% of total assets
Liquidity 67-25
short-term debt 63.5% · cash 59.4%
Profitability 100=
return on assets 34.7%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €3,000 on 30-day terms, only on tighter conditions: the latest accounts were filed more than 90 days after the deadline
Liquidity is tight, with a current ratio of 1.4 (3.42 in 2024), below the usual 1.5. Short-term debt is 63.5% and cash 59.4% of total assets. 69.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 27% of them on solvency, 46% on liquidity, 80% on profitability and 15% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 91 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Liquidity: current ratio 1.40, cash €110,371
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-10-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 91 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-10-2026, 91 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 3 filings
Deviation from the deadline
2025
91 days late
2024
60 days late
2023
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 60 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 September (3 of the last 3 accounts filed within 31 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Recent changes

  1. · Gazette deed IncorporationStarting capital €2,000 · Appointment: RAGBA Dounia (director)
All 5 events

Comparable companies

These companies have the same main activity as RDMed: general medical practice (NACE 86210). They are comparable in size and age: total assets between €187,000 and €201,000, founded between 2022 and 2023.

CompanyTotal assetsGross margin
RDMed Flémalle€185,830€93,066
CABINET MEDICAL DOCTEUR SIMON DELOGNE Liège€198,699€88,291
Dr. Nouwynck Lore Waregem€187,400€89,472
Dr. Sara Tack BV Ieper€196,768€93,485
Dr. Laura De Vriese Oostkamp€194,415€89,434
DOCTEUR TIZIANA BARBONI MEDICAL Charleroi€200,603€90,769
DR. CHARLOTTE PAS, HUISARTS Zulte€198,744€96,461
Full comparison

Key facts about RDMed

What is the company number of RDMed?
The company number of RDMed is 0791.532.866. The VAT number is the same number with BE in front: BE 0791.532.866.
Where is RDMed based?
The registered office is at Grand'Route(Flh) 506, 4400 Flémalle.Company details
What does RDMed do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of RDMed?
The legal form of RDMed is Private limited company (BV).
When was RDMed founded?
RDMed was founded on 28-09-2022.
Is RDMed still active?
Yes, RDMed is an active enterprise in the KBO register.
What is the turnover of RDMed?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €93,066 and 32 comparable companies (NACE 862). It probably lies between €160,000 and €270,000.Financials
Is RDMed profitable?
In financial year 2025, RDMed made a profit of €64,527.
Where can I find the annual accounts of RDMed?
RDMed filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RDMed due?
RDMed must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.